Timing between rituximab and 90Y-ibritumomab tiuxetan in pts with Non-Hodgkin's lymphoma does not affect clinical outcomes.

被引：0
|
作者：
Friedman, Isaiah E.
Andreadis, Charalambos
Diangi, Yumi Taylor
Nasta, Sunita D.
Luger, Selina M.
Stadtmauer, Edward A.
Schuster, Stephen J.
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4735
引用
收藏
页码：267B / 267B
页数：1
相关论文
共 50 条
  • [21] 90Y-ibritumomab tiuxetan (Zevalin®) consolidation in non-Hodgkin's B lymphoma: severe haematological toxicity reported in two Mantle patients
    Pena, F. J.
    Crespo-Jara, A.
    Sureda, M.
    Redal, M. C.
    Garcia-Cases, F.
    Rebello, J.
    Fernandez, P. L.
    Evgenyeva, E.
    Brugarolas, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S149 - S149
  • [22] Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
    McKinney, Matthew S.
    Beaven, Anne W.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2014, 4 : 45 - 59
  • [23] 90Yttrium-ibritumomab tiuxetan:: a novel treatment for non-Hodgkin's lymphoma
    Blum, KA
    Bartlett, NL
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) : 1323 - 1331
  • [24] Assessment of Metabolic Response to Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
    Storto, Giovanni
    De Renzo, Amalia
    Pellegrino, Teresa
    Perna, Fabiana
    De Falco, Teresa
    Erra, Paola
    Nardelli, Anna
    Speranza, Antonio
    Klain, Michele
    Rotoli, Bruno
    Pace, Leonardo
    RADIOLOGY, 2010, 254 (01) : 245 - 252
  • [25] 90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging
    Iagaru, Andrei
    Gambhir, Sanjiv Sam
    Goris, Michael L.
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (11) : 1809 - 1812
  • [26] Safety and efficacy of retreating follicular non-Hodgkin's lymphoma with 90Y ibritumomab tiuxetan (zevalin).
    Shah, J.
    Mueh, I.
    Lister, J.
    Jasthy, S.
    Gregory, M.
    Mckay, C.
    Krumdieck, R.
    Forero, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S303 - S303
  • [27] Efficacy of 90Y-Ibritumomab Tiuxetan in the Older Population with Non-Hodgkin Lymphoma Pre-Treated with Rituximab-Based Regimens: A Single-Institution Experience
    Agrawal, Vaibhav
    Diane, Smelser T.
    Castillo, Jose I.
    Raup, Kelly
    Treanna, Girton D.
    Collins, Scotty R.
    Brady, James O.
    Khan, Sharif S.
    BLOOD, 2017, 130
  • [28] 90Y-IBRITUMOMAB TIUXETAN TREATMENT FOR RELAPSED AND/OR REFRACTORY B CELL NON-HODGKIN'S LYMPHOMA. MULTI-INSTITUTIONAL ARGENTINIAN STUDY
    Cacchione, R.
    Milone, J.
    Nucifora, E.
    Bordone, J.
    Dupont, J.
    Rudoy, S.
    Brown, M.
    Lafalce, D.
    Palmer, L.
    Argentieri, D.
    Negri, P.
    Bartomioli, M.
    Milone, G.
    Trouboul, A.
    Ardaiz, M.
    Iabstrebner, M.
    Pombo, G.
    Basso, A.
    Diaz, A.
    Tur, R.
    Saidon, G.
    Krupitzki, H.
    Garay, G.
    Riveros, D.
    Carrasco, A.
    Chiattone, C.
    Bezares, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 109 - 109
  • [29] Radioimmunotherapy with 90Y-Zevalin (90y-Ibritumomab Tiuxetan) in Patients with Non Hodgkin Lymphoma: Preliminary Experience of our Centre
    Vallejos, V.
    Calvo, E.
    Xicoy, B.
    Riba, J.
    Rubio, A.
    Sola, M.
    Mila, M.
    Rosado, M.
    Ribera, J. M.
    Fraile, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S352 - S353
  • [30] Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET
    Saiyada N. F. Rizvi
    Otto J. Visser
    Maria J. W. D. Vosjan
    Arthur van Lingen
    Otto S. Hoekstra
    Josée M. Zijlstra
    Peter C. Huijgens
    Guus A. M. S. van Dongen
    Mark Lubberink
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 512 - 520
12345